Are There Any Research Advances for Delta F508 Mutation?
Research on CF, including the Delta F508 mutation, is ongoing. Scientists are exploring gene therapy, which aims to correct the defective CFTR gene. Additionally, researchers are investigating new CFTR modulators and combination therapies to improve the function of the CFTR protein. Clinical trials are crucial for testing these new treatments and bringing them to the market.
